Catalent Inc (NYSE:CTLT)
$ 55.61 0.09 (0.16%) Market Cap: 10.06 Bil Enterprise Value: 14.88 Bil PE Ratio: 0 PB Ratio: 2.79 GF Score: 81/100

Q2 2020 Catalent Inc Earnings Call Transcript

Feb 03, 2020 / 01:15PM GMT
Release Date Price: $61.65 (+0.90%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Catalent Second Quarter Fiscal Year 2020 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Paul Surdez, Vice President, Investor Relations. Thank you. Please go ahead, sir.

Paul Surdez
Catalent, Inc. - VP of IR

Good morning, everyone, and thank you for joining us today to review Catalent's Second Quarter Fiscal Year 2020 Financial Results. With me today are John Chiminski, Chair and Chief Executive Officer; and Wetteny Joseph, Senior Vice President and Chief Financial Officer.

In addition to reviewing our second quarter earnings release issued earlier this morning, we will also refer you to our other press release issued today regarding our agreement to acquire cell therapy leader, MaSTherCell. Please see our agenda for this call on Slide 2 of our supplemental presentation, which is available on our Investor Relations

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot